文献速递疼痛医学区域麻醉与超声

超声引导经皮临时迷走神经刺激治疗创伤后慢性疼痛与PTSD首例报告

Ultrasound-guided percutaneous temporary vagus nerve stimulation for refractory post-traumatic chronic pain and post-traumatic stress disorder (PTSD): first reported case and implantation technique.
PubMed 文献 · Reg Anesth Pain Med · 2026-09-11

本文报告一例女性患者,在多次创伤性脑损伤后出现难治性慢性疼痛综合征、PTSD、创伤后头痛及枕神经痛。采用超声引导经皮植入左侧迷走神经外周神经刺激器60天,8周内疼痛评分从10/10降至0/10,胃肠道症状、疲劳及PTSD症状缓解,4个月随访镇痛效果持续,但PCL-5评分随访期间升高,且缺乏基线PCL-5评分。

要点

  • 超声引导经皮临时迷走神经刺激可用于难治性创伤后慢性疼痛与PTSD。
  • 60天临时植入期间疼痛评分从10/10降至0/10,4个月随访镇痛持续。
  • PCL-5评分随访期间升高,且缺乏基线值,PTSD改善幅度无法确定。

核心结论

  • 超声引导经皮60天临时迷走神经刺激可用于PTSD和创伤后慢性疼痛,并附植入技术描述。

研究设计与样本

  • 病例报告:一名20多岁女性,多次创伤性脑损伤后出现难治性慢性疼痛综合征、PTSD、创伤后头痛及枕神经痛。

主要发现

  • 8周临时植入期间疼痛评分从10/10降至0/10,胃肠道症状、疲劳及PTSD症状同时缓解。
  • 4个月随访时镇痛改善持续,但PCL-5评分在同一时间区间升高。
  • 因缺乏术前基线PCL-5评分,无法确定PTSD症状相对治疗前的变化幅度。

关键数值与推荐

  • 左侧迷走神经外周神经刺激器经超声引导经皮植入,临时植入60天。
  • 疼痛评分从10/10降至0/10(8周植入期间),4个月随访镇痛持续。
  • PTSD症状采用DSM-5 PTSD检查表(PCL-5)测量,随访期间评分升高。

临床怎么用

  • 对难治性创伤后慢性疼痛合并PTSD患者,可考虑超声引导经皮临时迷走神经刺激。
  • 植入前应采集PCL-5基线评分,以便评估PTSD症状变化。

局限性

  • 单例病例报告,结论不能推广。
  • 缺乏术前基线PCL-5评分,无法确定PTSD症状相对治疗前的变化幅度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Post-traumatic stress disorder (PTSD) and chronic pain frequently coexist and are often refractory to conventional therapies. Vagus nerve stimulation (VNS) has emerged as a potential neuromodulatory approach targeting autonomic dysregulation and central pain pathways. VNS has traditionally been delivered using either transcutaneous approaches or surgical implantation; however, to the best of our knowledge, ultrasound-guided percutaneous peripheral nerve stimulation targeting the vagus nerve has not previously been described. CASE REPORT: We present the case of a female in her late 20s with refractory chronic pain syndrome, PTSD, post-traumatic headaches, and occipital neuralgia following multiple traumatic brain injuries sustained during domestic violence. After failing conservative management, the patient underwent ultrasound-guided percutaneous implantation of a left vagus nerve peripheral nerve stimulator for 60 days and demonstrated remarkable improvement. Over an 8-week period of temporary implantation, pain scores decreased from 10/10 to 0/10, with concomitant resolution of gastrointestinal symptoms, fatigue, and PTSD symptoms. Analgesic improvement was sustained at 4-month follow-up, while PTSD symptom scores measured using the PTSD Checklist for DSM-5 (PCL-5) increased during the same time interval. Because a baseline pre-procedure PCL-5 score was not available, the overall magnitude of change relative to the patient's pretreatment status cannot be determined despite PTSD symptom scores increasing during follow-up. CONCLUSIONS: We present the use of the 60-day percutaneous temporary implantation of VNS for PTSD and chronic post-traumatic pain, along with a detailed description of the ultrasound-guided implantation technique.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Elsharkawy H, Ajon AB, Elsharkawy K, et al. Ultrasound-guided percutaneous temporary vagus nerve stimulation for refractory post-traumatic chronic pain and post-traumatic stress disorder (PTSD): first reported case and implantation technique. Reg Anesth Pain Med. 2026. PMID: 42727982. doi:10.1136/rapm-2026-108153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。